Protective effects of buflomedil against exercise-induced reductions in regional erythrocyte deformability of patients with peripheral arterial disease.
D001157:Arterial Occlusive Diseases / Q000097:blood*; D004912:Erythrocytes / Q000187:drug effects / Q000502:physiology*; D005260:Female; D006801:Humans; D007773:Lactates / Q000097:blood; D019344:Lactic Acid; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D005082:Physical Exertion; D011759:Pyrrolidines / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*
D007773:Lactates; D011759:Pyrrolidines; D014665:Vasodilator Agents; D019344:Lactic Acid; D010100:Oxygen; C010651:buflomedil